StockWatch
·
Medical Equipment & Supplies
Board Meeting31 Oct 2026, 10:30 pm

Earkart Ltd Board Meeting on Nov 5 to Approve H1 FY27 Results, Australian Subsidiary

AI Summary

Earkart Ltd has announced a Board of Directors meeting scheduled for November 5, 2026. The primary agenda items include the consideration and approval of the unaudited half-yearly financial results for the period ended September 30, 2026. Additionally, the board will discuss and potentially approve the incorporation of a Wholly Owned Subsidiary in Australia. In line with SEBI regulations, the trading window for company securities will remain closed until November 7, 2026, to prevent insider trading, though it will be open for general investors. The company will make the financial results available on its website.

Key Highlights

  • Board meeting scheduled for November 5, 2026.
  • Agenda includes approval of unaudited half-yearly financial results.
  • Proposal to incorporate a Wholly Owned Subsidiary in Australia.
  • Trading window closed until November 7, 2026, for insider trading prevention.